High incidence of amantadine-resistant influenza AH3 viruses isolated during the 2005-2006 winter season in Nara, Japan

Japanese Journal of Infectious Diseases

Volumn 60, Issue 1, 2007, Pages 53-54

  Yoneda, Masaki ^a   Inoue, Yumiko ^a   Kitahori, Yoshiteru ^a  

^a Nara Prefectural Institute for Hygiene and Environment   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; AMANTADINE; ASPARAGINE; PROTEIN M2; SERINE; VALINE;

AMINO ACID SUBSTITUTION; ARTICLE; GENETIC ANALYSIS; HUMAN; INCIDENCE; INFLUENZA VIRUS; INFLUENZA VIRUS AH3; JAPAN; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; STRAIN IDENTIFICATION; VIRUS ISOLATION; VIRUS RESISTANCE; VIRUS STRAIN; VIRUS TRANSMISSION; WINTER;

AMANTADINE; DRUG RESISTANCE, VIRAL; HUMANS; INFLUENZA A VIRUS; INFLUENZA, HUMAN; JAPAN; POINT MUTATION; VIRAL MATRIX PROTEINS;

EID: 33947409462     PISSN: 13446304     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Ziegler, T., Hemphill, M.L., Ziegler, M.L., et al. (1999): Low incidence of rimantadine resistance in field isolates of influenza A viruses. J. Infect. Dis., 180, 935-939.
2. Kitahori, Y., Nakano, M. and Inoue, Y. (2006): Frequency of amantadine-resistant influenza A virus isolated from 2001-02 to 2004-05 in Nara Prefecture. Jpn. J. Infect. Dis., 59, 197-199.
3. Bright, R.A., Medina, M.J., Xu, X., et al. (2005): Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern. Lancet, 366, 1175-1181.
4. Bright, R.A., Shay, D.K., Shu, B., et al. (2006): Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States. JAMA, 295, 934-936.
5. Saito, R., Oshitani, H., Masuda, H., et al. (2002): Detection of amantadine-resistant influenza A virus strains in nursing homes by PCR-restriction fragment length polymorphism analysis with nasopharyngeal swabs. J. Clin. Microbiol., 40, 84-88.
6. Belsh,e, R.B., Smith, M.H., Hall, C.B., et al. (1988): Genetic basis of resistance to rimantadine emerging during treatment of influenza virus infection. J. Virol., 62, 1508-1512.
7. Suzuki H., Saito, R., Masuda, H., et al. (2003): Emergence of amantadine-resistant influenza A viruses: epidemiological study. J. Infect. Chemother., 9, 195-200.
8. Masuda, H., Suzuki, H., Oshitani, H., et al. (2000): Incidence of amantadine-resistant influenza A viruses in sentinel surveillance sites and nursing homes in Niigata, Japan. Microbiol. Immunol., 44, 833-839.
9. Barr, I.G., Hurt, A.C., Iannello, P., et al. (2007): Increased adamantane resistance in influenza A(H3) viruses in Australia and neighboring countries in 2005. Antiviral Res., 73, 112-117.
10. Saito, R., Li, D., Shimomura, C., et al. (2006): An off-seasonal amantadine resistant H3N2 influenza outbreak in Japan. Tohoku J. Exp. Med., 210, 21-27.
11. Cheung, C.L., Rayner, J.M., Smith, G.J.D., et al. (2006): Distribution of amantadine-resistant H5N1 avian influenza variants in Asia. J. Infect. Dis., 193, 1626-1629.